Format

Send to:

Choose Destination
See comment in PubMed Commons below
Schizophr Res Treatment. 2011;2011:596898. doi: 10.1155/2011/596898. Epub 2011 Jan 16.

Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial.

Author information

  • 1Mental Health and Neurodegeneration Research Group, The University of Manchester, Manchester M13 9PL, UK.

Abstract

The impact of antipsychotic drug treatment on sexual function was investigated during a randomised trial comparing first generation antipsychotics (FGAs) to (nonclozapine) second generation antipsychotics (SGAs). Sexual function and quality of life were (rater-blind) assessed in 42 patients with DSM-IV schizophrenia (aged 18-65) using the self-report version of the Derogatis Interview for Sexual Function (DISF-SR) and the Heinrichs Quality of Life Scale (QLS), prior to, and 12 weeks following, a change in medication from an FGA drug to either an FGA or SGA drug. SGAs significantly improved sexual function compared to FGAs. Change in sexual function was associated with change in quality of life. Where impaired sexual functioning is a distressing adverse effect of treatment with an FGA agent, consideration should be given to switching to an SGA.

PMID:
22937269
[PubMed]
PMCID:
PMC3428616
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Write to the Help Desk